These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 15930309

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 26. Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models.
    Rödel F, Frey B, Leitmann W, Capalbo G, Weiss C, Rödel C.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):247-55. PubMed ID: 18406888
    [Abstract] [Full Text] [Related]

  • 27. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K, Ishii N.
    Oncol Rep; 2006 Aug 01; 16(2):389-92. PubMed ID: 16820920
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2009 Sep 01; 117(2):261-71. PubMed ID: 18815881
    [Abstract] [Full Text] [Related]

  • 31. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM, Luan XY, Lei DP, Ma XJ, Liu XX, Liu J, Pan XL.
    ORL J Otorhinolaryngol Relat Spec; 2008 Sep 01; 70(3):168-75. PubMed ID: 18391576
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
    Calviello G, Resci F, Serini S, Piccioni E, Toesca A, Boninsegna A, Monego G, Ranelletti FO, Palozza P.
    Carcinogenesis; 2007 Jun 01; 28(6):1202-9. PubMed ID: 17183061
    [Abstract] [Full Text] [Related]

  • 34. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate.
    McLaughlin N, Annabi B, Bouzeghrane M, Temme A, Bahary JP, Moumdjian R, Béliveau R.
    Brain Res; 2006 Feb 03; 1071(1):1-9. PubMed ID: 16412397
    [Abstract] [Full Text] [Related]

  • 35. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA, Niu MY, Renart LI.
    Apoptosis; 2006 Apr 03; 11(4):589-605. PubMed ID: 16528475
    [Abstract] [Full Text] [Related]

  • 36. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
    Kappler M, Bache M, Bartel F, Kotzsch M, Panian M, Würl P, Blümke K, Schmidt H, Meye A, Taubert H.
    Cancer Gene Ther; 2004 Mar 03; 11(3):186-93. PubMed ID: 14739938
    [Abstract] [Full Text] [Related]

  • 37. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.
    Jpn J Clin Oncol; 2005 Aug 03; 35(8):453-63. PubMed ID: 16024531
    [Abstract] [Full Text] [Related]

  • 38. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
    Pennati M, Binda M, De Cesare M, Pratesi G, Folini M, Citti L, Daidone MG, Zunino F, Zaffaroni N.
    Carcinogenesis; 2004 Jul 03; 25(7):1129-36. PubMed ID: 14764461
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H, Niederkorn JY, Neelam S, Alizadeh H.
    Exp Eye Res; 2006 Jul 03; 83(1):176-82. PubMed ID: 16584731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.